-
-
Login
NICE has backed once-weekly insulin efsitora alfa, branded Onswik, for type 2 diabetes manangement. It could mean 313 fewer basal injections a year, fewer needles and less pressure on injection sites, while delivering glucose control comparable with daily insulin.
MiniMed is reshaping its insulin pump range. Flex has launched in the US, while its first tubeless patch pump, MiniMed Fit, has now been submitted to the FDA with a US launch targeted for summer 2027.
Abbott employees, a former Eli Lilly scientist, a healthcare lawyer and a university researcher have all appeared around Love My Libre. As Abbott challenges the Libreband trade mark, we ask whether these really are unrelated coincidences.
New research analysing almost 47 million CGM readings reveals how often glucose reaches a sensor's measurement limits, how long it can remain there and what that means for the information we see.
Apple is reportedly exploring a screenless health and fitness band that could compete with wearables such as Whoop. Recent events show how this increasing trend has a curious link to our own products
Abbott and Google plan one of the largest real-world metabolic health studies to date, with consumers buying the sensors and supplying the health data that builds AI they won't own. This isn't simply about Lingo: it could shape the future of CGM, who controls the intelligence behind our glucose data and ultimately how diabetes is managed.
Summer 2026 has brought important developments across FreeStyle Libre, from Libre 3 Plus and rapid growth in hybrid closed-loop use to new ADA evidence supporting Libre Duo, AI-powered Libre Assist and Abbott's wider move into connected health.
Dexcom's latest announcements aren't just about a smaller sensor or longer wear. From G8 and hybrid closed-loop technology to Stelo, digital health and the wider CGM community, Summer 2026 reveals a company whose ambitions increasingly extend beyond diabetes sensors and towards a connected health platform.
Insulet's latest Omnipod 6 announcements go beyond a smarter insulin pump. New clinical data and fresh insights into fully closed-loop technology reveal how the company hopes to reduce the daily burden of living with diabetes while raising important questions about automation, data and control.
For years, type 2 diabetes has been linked to carrying too much body fat. But new research suggests the story may be more complicated. According to scientists, it's not just how much fat you have that matters. It's whether your body can still use it properly.
A research smart ring can monitor glucose and ketones from sweat continuously. It's an exciting step, but it remains a long way from replacing CGMs.
